Business
First patient dosed in Phase 1/2 trial of CHM CDH17
First patient dosed in Phase 1/2 trial of CHM CDH17
About this update from Chimeric Therapeutics Limited
[{"type":"text","content":"Chimeric Therapeutics Ltd has released a press release. View Attachment","length":246,"tagName":"div"}]